Skip to main content

Advertisement

SpringerLink
Log in

Pathology and diagnosis of renal non-AL amyloidosis

  • Review
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Renal amyloidosis is characterized by acellular Congo red positive deposits in the glomeruli, interstitium and/or arteries. Light chain restriction on immunofluorescence studies is present in AL-amyloidosis, the most common type of amyloidosis involving the kidney. The detection of Congo red positive deposits coupled with negative immunofluorescence studies is highly suggestive of non-AL amyloidosis. Some of the non-AL amyloidosis are common while others are relatively rare. The clinical features, laboratory and renal pathology findings are helpful in the diagnosis and typing of non-AL amyloidosis. Thus, ALECT2 amyloidosis is characterized by diffuse cortical interstitial amyloid deposits, AA amyloidosis shows vascular deposits in addition to the glomerular deposits, AFib amyloidosis is characterized by massive amyloid accumulation limited to the glomeruli resulting in the obliteration of glomerular architecture, AApoA1 and AApoAIV are characterized by large amyloid deposits restricted to the medulla, and AGel shows swirling patterns of amyloid fibrils on electron microscopy. While light microscopy is very helpful, accurate typing of non-AL amyloidosis then requires immunohistochemical or laser microdissection/mass spectrometry studies of the Congo red positive deposits. Immunohistochemical studies are available for some of the non-AL amyloidosis. On the other hand, mass spectrometry analysis is a one stop methodology for confirmation and typing of amyloidosis. The diagnosis and typing of amyloidosis by mass spectrometry is based on finding the signature amyloid peptides, apolipoprotein E and serum amyloid-P component, followed by detection of precursor amyloidogenic protein such as LECT2, fibrinogen-α, gelsolin, etc. To, summarize, non-AL amyloidosis is a group of amyloidosis with distinctive clinical, laboratory and renal pathology findings. Typing of the amyloidosis is best performed using mass spectrometry methodology. Accurate typing of non-AL amyloidosis is imperative for correct management, prognosis, and genetic counseling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dember LM (2006) Amyloidosis-associated kidney disease. J Am Soc Nephrol 17:3458–3471

    Article  CAS  PubMed  Google Scholar 

  2. Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583–596

    Article  CAS  PubMed  Google Scholar 

  3. Said SM, Sethi S, Valeri AM et al (2013) Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases. Clin J Am Soc Nephrol 8:1515–1523

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sethi S, Theis JD, Leung N et al (2010) Mass spectrometry based proteomic diagnosis of renal immunoglobulin heavy chain amyloidosis. Clin J Am Soc Nephrol 5:2180–2187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203

    Article  PubMed  Google Scholar 

  6. Vigushin DM, Gough J, Allan D et al (1994) Familial nephropathic systemic amyloidosis caused by apolipoprotein Al variant Arg26. QJM 87:149–154

    CAS  PubMed  Google Scholar 

  7. Yazaki M, Liepnieks JJ, Barats MS, Cohen AH, Benson MD (2003) Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 64:11–16

    Article  CAS  PubMed  Google Scholar 

  8. Yazaki M, Liepnieks JJ, Yamashita T, Guenther B, Skinner M, Benson MD (2001) Renal amyloidosis caused by a novel stop-codon mutation in the apolipoprotein A-II gene. Kidney Int 60:1658–1665

    Article  CAS  PubMed  Google Scholar 

  9. Benson M JL, Uemichi T, Wheeler G, Correa R (1993) Hereditary renal amyloidosis associated with a mutant fibrinogen [alpha]-chain. Blood 3:252–255

    Google Scholar 

  10. Benson MD (2005) Ostertag revisited: the inherited systemic amyloidoses without neuropathy. Amyloid 12:75–87

    Article  CAS  PubMed  Google Scholar 

  11. Joy T, Wang J, Hahn A, Hegele RA (2003) Apoa1 related amyloidosis: a case report and literature review. Clin Biochem 36:641–645

    Article  CAS  PubMed  Google Scholar 

  12. Gillmore JD, Booth DR, Madhoo S, Pepys MB, Hawkins PN (1999) Hereditary renal amyloidosis associated with variant lysozyme in a large English family. Nephrol Dial Transplant 14:2639–2644

    Article  CAS  PubMed  Google Scholar 

  13. Dasari S, Amin MS, Kurtin PJ et al. Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis. Kidney International;90:658–664

  14. Sethi S, Dasari S, Amin MS et al (2017) Clinical, biopsy, and mass spectrometry findings of renal gelsolin amyloidosis. Kidney Int 91:964–971

    Article  CAS  PubMed  Google Scholar 

  15. Lachmann HJ, Goodman HJB, Gilbertson JA et al (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361–2371

    Article  CAS  PubMed  Google Scholar 

  16. Chugh KS, Datta, Singhal PC, Jain S, Sakhuja V, Dash SC (1981) Pattern of renal amyloidosis in indian patients. Postgrad Med J 57:31–35

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Verine J, Mourad N, Desseaux K et al (2007) Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response. Hum Pathol 38:1798–1809

    Article  PubMed  Google Scholar 

  18. Saha A, Chopra Y, Theis JD, Vrana JA, Sethi S (2013) AA amyloidosis associated with systemic-onset juvenile idiopathic arthritis. Am J Kidney Dis 62:834–838

    Article  PubMed  Google Scholar 

  19. Lane T, Loeffler JM, Rowczenio DM et al (2013) Brief report: AA amyloidosis complicating the hereditary periodic fever syndromes. Arthritis Rheum 65:1116–1121

    Article  CAS  PubMed  Google Scholar 

  20. Benson MD, James S, Scott K, Liepnieks JJ, Kluve-Beckerman B (2008) Leukocyte chemotactic factor 2: A novel renal amyloid protein. Kidney Int 74:218–222

    Article  CAS  PubMed  Google Scholar 

  21. Said SM, Sethi S, Valeri AM et al (2014) Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int 86:370–377

    Article  CAS  PubMed  Google Scholar 

  22. Nasr SH, Dogan A, Larsen CP (2015) Leukocyte cell–derived chemotaxin 2–associated amyloidosis: a recently recognized disease with distinct clinicopathologic characteristics. Clin J Am Soc Nephrol 10:2084–2093

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Paueksakon P, Fogo AB, Sethi S (2014) Leukocyte chemotactic factor 2 amyloidosis cannot be reliably diagnosed by immunohistochemical staining. Hum Pathol 45:1445–1450

    Article  CAS  PubMed  Google Scholar 

  24. Gillmore JD, Lachmann HJ, Rowczenio D et al (2009) Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen Aα-chain amyloidosis. J Am Soc Nephrol 20:444–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Uemichi T, Liepnieks JJ, Benson MD (1994) Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 93:731–736

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Stangou AJ, Banner NR, Hendry BM et al (2010) Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood 115:2998–3007

    Article  CAS  PubMed  Google Scholar 

  27. Gillmore JD, Booth DR, Rela M et al (2000) Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen {alpha}-chain variant in an English family. QJM 93:269–275

    Article  CAS  PubMed  Google Scholar 

  28. Sethi S, Ters ME, Vootukuru S, Qian Q (2011) Recurrent AA amyloidosis in a kidney transplant. Am J Kidney Dis 57:941–944

    Article  PubMed  Google Scholar 

  29. Meretoja J (1969) Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1:314–324

    CAS  PubMed  Google Scholar 

  30. Maury CPJ, Alii K, Baumann M (1990) Finnish hereditary amyloidosis. FEBS Lett 260:85–87

    Article  CAS  PubMed  Google Scholar 

  31. Maury CPJ, Kere J, Tolvanen R, de la Chapelle A (1990) Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 276:75–77

    Article  CAS  PubMed  Google Scholar 

  32. Maury CPJ, Kere J, Tolvanen R, de la Chapelle A (1992) Homozygosity for the Asn187 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 13:902–903

    Article  CAS  PubMed  Google Scholar 

  33. Sethi S, Theis JD, Quint P et al (2013) Renal Amyloidosis Associated With a Novel Sequence Variant of Gelsolin. Am J Kidney Dis 61:161–166

    Article  CAS  PubMed  Google Scholar 

  34. Gregorini G, Izzi C, Ravani P et al (2015) Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. Kidney Int 87:1223–1229

    Article  CAS  PubMed  Google Scholar 

  35. Rowczenio D, Dogan A, Theis JD et al (2011) Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-I. Am J Pathol 179:1978–1987

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Gregorini G, Izzi C, Obici L et al (2005) Renal apolipoprotein a-i amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis. J Am Soc Nephrol 16:3680–3686

    Article  CAS  PubMed  Google Scholar 

  37. Obici L, Palladini G, Giorgetti S et al (2004) Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families. Gastroenterology 126:1416–1422

    Article  PubMed  Google Scholar 

  38. Traynor CA, Tighe D, O’Brien FJ et al (2013) Clinical and pathologic characteristics of hereditary apolipoprotein A-I amyloidosis in Ireland. Nephrology 18:549–554

    Article  CAS  PubMed  Google Scholar 

  39. Gillmore JD, Stangou AJ, Lachmann HJ et al (2006) Organ Transplantation in Hereditary Apolipoprotein AI Amyloidosis. Am J Transplant 6:2342–2347

    Article  CAS  PubMed  Google Scholar 

  40. De Gracia R, Fernández EJ, Riñón C, Selgas R, Garcia-Bustos J (2006) Hereditary renal amyloidosis associated with a novel mutation in the apolipoprotein AII gene. QJM: An International. J Med 99:274-

    Google Scholar 

  41. Benson MD, Liepnieks JJ, Yazaki M et al (2001) A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene. Genomics 72:272–277

    Article  CAS  PubMed  Google Scholar 

  42. Sethi S, Theis JD, Shiller SM et al (2012) Medullary amyloidosis associated with apolipoprotein A-IV deposition. Kidney Int 81:201–206

    Article  CAS  PubMed  Google Scholar 

  43. Nasr SH, Dasari S, Hasadsri L et al (2017) Novel type of renal amyloidosis derived from apolipoprotein-CII. J Am Soc Nephrol 28:439–445

    Article  PubMed  Google Scholar 

  44. Valleix S, Drunat S, Philit J-B et al (2002) Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int 61:907–912

    Article  CAS  PubMed  Google Scholar 

  45. Granel B, Valleix S, Serratrice J et al (2006) Lysozyme amyloidosis: report of 4 cases and a review of the literature. Medicine (Baltimore) 85:66–73

    Article  Google Scholar 

  46. Nasr SH, Dasari S, Mills JR et al (2017) Hereditary lysozyme amyloidosis variant p.Leu102Ser associates with unique phenotype. J Am Soc Nephrol 28:431–438

    Article  PubMed  PubMed Central  Google Scholar 

  47. Sethi S, Vrana JA, Theis JD, Dogan A (2013) Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens 22:273–280

    Article  CAS  PubMed  Google Scholar 

  48. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, Dogan A (2009) Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens. Blood 114:4957–4959

    Article  CAS  PubMed  Google Scholar 

  49. Dasari S, Theis JD, Vrana JA et al (2014) Clinical proteome informatics workbench detects pathogenic mutations in hereditary amyloidoses. J Proteome Res 13:2352–2358

    Article  CAS  PubMed  Google Scholar 

  50. Sethi S, Vrana JA, Theis JD et al (2012) Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis. Kidney Int 82:226–234

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA

    Sanjeev Sethi & Jason D. Theis

Authors
  1. Sanjeev Sethi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jason D. Theis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sanjeev Sethi.

Ethics declarations

Conflict of interest

All authors declare that they do not have competing interests.

Ethical approval

This article does not contain any studies with human participants performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sethi, S., Theis, J.D. Pathology and diagnosis of renal non-AL amyloidosis. J Nephrol 31, 343–350 (2018). https://doi.org/10.1007/s40620-017-0426-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-017-0426-6

Keywords

Search

Navigation